Growth Metrics

Beta Bionics (BBNX) Gains from Investment Securities (2023 - 2026)

Beta Bionics' Gains from Investment Securities history spans 4 years, with the latest figure at $1000.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities fell 99.97% to $1000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$8.6 million, a 221.38% decrease, with the full-year FY2025 number at $6.5 million, up 13.86% from a year prior.
  • Gains from Investment Securities hit $1000.0 in Q1 2026 for Beta Bionics, up from -$12.4 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for BBNX hit a ceiling of $5.2 million in Q4 2023 and a floor of -$12.4 million in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $461916.1 across 4 years, with a median of $156340.0 in 2025.
  • The widest YoY moves for Gains from Investment Securities: up 137.31% in 2025, down 1241900.0% in 2025.
  • Tracing BBNX's Gains from Investment Securities over 4 years: stood at $5.2 million in 2023, then crashed by 100.02% to -$1000.0 in 2024, then plummeted by 1241900.0% to -$12.4 million in 2025, then soared by 100.01% to $1000.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for BBNX at $1000.0 in Q1 2026, -$12.4 million in Q4 2025, and $156340.0 in Q3 2025.